Donor Smoking and Older Age Increases Morbidity and Mortality After Lung Transplantation
Maura Iversen
Part of the Medicine and Health Sciences Commons
Works by M. Iversen in Medicine and Health Sciences
2017
2016
AB1090-HPR Use of Theory in Self-Management Interventions for Exercise and Physical Activity in Adults with Rheumatoid Arthritis
Maura Iversen
AB0587 Pulmonary Arterial Hypertension as A Risk Factor for Mortality in Connective Tissue Disease with Biopsy Proven Interstitial Lung Disease
Maura Iversen
FRI0651-HPR Three Year Trends in Physical Activity in Adults with Rheumatoid Arthritis
Maura Iversen
Outcomes in Lung Transplantation Following Allogeneic Stem-Cell Transplantation: A Pan-European Experience
Maura Iversen
2015
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections
Maura Iversen
OP0103 Comparative Effectiveness of Tai Chi Versus Physical Therapy in Treating Knee Osteoarthritis: A Randomized, Single-Blind Trial
Maura Iversen
Long Term Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial
Maura Iversen
2014
Restrictive Allograft Syndrome (RAS) in Lung Transplant Recipients Carries Uncertain Additional Prognostic Significance as Compared To BOS
Maura Iversen
Age-Related Decline in Lung Function in Patients Without CLAD After Double Lung Transplantation
Maura Iversen
2013
WS1.5 First evidence of Mycobacterium abscessus biofilm in the lungs of chronically infected CF patients
Maura Iversen
Lung Transplant Recipients Suspected of Antibody Mediated Rejection Treated with Plasmapheresis Have a Poor Prognosis
Maura Iversen
Long Term Outcome after Bronchial Artery Revascularization in Double Lung Transplantation – A More Than Fifteen Year Follow-Up Study
Maura Iversen
Time after Lung Transplantation Influence the Correlation between Acute Rejection and Frequency of Regulatory T Cells in Transbronchial Lung Biopsies
Maura Iversen
The Time Course of Development and Impact From Viral Resistance Against Ganciclovir in Cytomegalovirus Infection
Maura Iversen
Nontuberculous Mycobacterial Disease Is Not a Contraindication to Lung Transplantation in Patients With Cystic Fibrosis: A Retrospective Analysis in a Danish Patient Population
Maura Iversen
2012
526 Chronic Allograft Dysfunction after Lung Transplantation. A Comparison of RAS vs. BOS
Maura Iversen
407 Regulatory T Cells in Transbronchial Biopsies Compared with FoxP3 mRNA Level in Bronchoalveolar Lavage Fluid
Maura Iversen
726 Endoscopic Treatment of Native Lung Hyperinflation with One-Way Valves in Single Lung Transplant Patients: A Multinational Experience
Maura Iversen
823 Impact of Pulmonary Venous Hypertension on Prognosis and Outcome after Lung Transplantation for End-Stage Chronic Obstructive Pulmonary Disease
Maura Iversen
2011
Erratum to: Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Maura Iversen
Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation
Maura Iversen
224 Nontuberculous mycobacterial infections among cystic fibrosis patients undergoing lung transplantation
Maura Iversen
226 Lung transplant patients with cystic fibrosis attain lower blood concentrations of cyclosporine compared to other lung transplant patients
Maura Iversen
53 Everolimus Introduction and Calcineurin Reduction in Thoracic Transplant Recipients with Advanced Chronic Renal Failure
Maura Iversen
Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228–1237
Maura Iversen
Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
Maura Iversen
2010
132: Everolimus Introduction with CNI Minimization Significantly Improves Renal Function in Thoracic Transplant Recipients: A Scandinavian Multicenter, Randomized Study
Maura Iversen
A Blinded Randomized Controlled Trial of Motivational Interviewing to Improve Adherence with Osteoporosis Medications: Design of the OPTIMA Trial
Maura Iversen
2009
Rapid decline in 51Cr-EDTA measured renal function during the first weeks following lung transplantation.
Maura Iversen
317: Does Ciclosporine C2 Levels Determine Outcome in De Novo Heart and Lung Transplant Patients: Results from the NOCTURNE Nordic Multi Centre Study
Maura Iversen
2008
212: An Analysis of 2697 Transbronchial Biopsies: Is Lymphocytic Bronchiolitis a Marker of Acute Rejection?
Maura Iversen
530: Microarray Based Measurement of Autoantibodies Identifies Early Development of BOS in Lung Transplant Patients
Maura Iversen
86: Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation
Maura Iversen
111: Bronchiolitis Obliterans Organizing Pneumonia (BOOP) after Lung Transplantation: A Potentially Reversible Prelude to Bronchiolitis Obliterans?
Maura Iversen
85: Diffuse Alveolar Damage (DAD) after Lung Transplantation: Early Pulmonary Injury Was Not Associated with the Development of Bronchiolitis Obliterans
Maura Iversen
2007
Physical activity counteracts increased whole-body protein breakdown in chronic obstructive pulmonary disease patients.
Maura Iversen
Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Maura Iversen
353: Pulmonary arterial hypertension in end-stage pulmonary sarcoidosis: Assessment of the therapeutic effect of sildenafil
Maura Iversen
2006
381: Histological appearances in patients with radiologically defined primary graft dysfunction (PGD)
Maura Iversen
2005
Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells
Maura Iversen
A comparison between antithymocyte globulin and dacluzimab induction therapy for lung transplantation. A retrospective analysis of the frequency of acute cellular rejection in 270 patients
Maura Iversen